ES557391A0 - Un procedimiento para la preparacion de espiro(imidazolidin-4,4'-(3'h)quinolinas) - Google Patents

Un procedimiento para la preparacion de espiro(imidazolidin-4,4'-(3'h)quinolinas)

Info

Publication number
ES557391A0
ES557391A0 ES557391A ES557391A ES557391A0 ES 557391 A0 ES557391 A0 ES 557391A0 ES 557391 A ES557391 A ES 557391A ES 557391 A ES557391 A ES 557391A ES 557391 A0 ES557391 A0 ES 557391A0
Authority
ES
Spain
Prior art keywords
quinolins
imidazolidin
spiral
procedure
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES557391A
Other languages
English (en)
Other versions
ES8801830A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Publication of ES8801830A1 publication Critical patent/ES8801830A1/es
Publication of ES557391A0 publication Critical patent/ES557391A0/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Peptides Or Proteins (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ES557391A 1985-05-29 1987-02-13 Un procedimiento para la preparacion de espiro(imidazolidin-4,4'-(3'h)quinolinas) Expired ES8801830A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/738,924 US4575507A (en) 1985-05-29 1985-05-29 Spiro-imidazolidines as aldose reductase inhibitors and their pharmaceutical use

Publications (2)

Publication Number Publication Date
ES8801830A1 ES8801830A1 (es) 1988-02-16
ES557391A0 true ES557391A0 (es) 1988-02-16

Family

ID=24970055

Family Applications (2)

Application Number Title Priority Date Filing Date
ES555375A Expired ES8800228A1 (es) 1985-05-29 1986-05-27 Un procedimiento para la preparacion de espiro (imidiazolina-4,1'-(2'h)-naftaleno) y espiro (croman-4,4'-imidazolidinas)
ES557391A Expired ES8801830A1 (es) 1985-05-29 1987-02-13 Un procedimiento para la preparacion de espiro(imidazolidin-4,4'-(3'h)quinolinas)

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES555375A Expired ES8800228A1 (es) 1985-05-29 1986-05-27 Un procedimiento para la preparacion de espiro (imidiazolina-4,1'-(2'h)-naftaleno) y espiro (croman-4,4'-imidazolidinas)

Country Status (21)

Country Link
US (1) US4575507A (es)
EP (1) EP0203791B1 (es)
JP (1) JPS61277671A (es)
KR (1) KR890001548B1 (es)
AT (1) ATE46332T1 (es)
AU (1) AU560429B2 (es)
DD (5) DD251972A5 (es)
DE (1) DE3665584D1 (es)
DK (1) DK248886A (es)
EG (1) EG17859A (es)
ES (2) ES8800228A1 (es)
FI (1) FI862251L (es)
GR (1) GR861388B (es)
HU (4) HU199845B (es)
IL (1) IL78954A (es)
NO (1) NO862123L (es)
NZ (1) NZ216334A (es)
PH (1) PH22213A (es)
PL (5) PL146020B1 (es)
PT (1) PT82650B (es)
ZA (1) ZA863934B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU198212B (en) * 1984-07-20 1989-08-28 Pfizer Process for production of spiro-imidasolones
US4762839A (en) * 1985-06-06 1988-08-09 Tanabe Seiyaku Co., Ltd. Quinazolinone copmpounds useful for the prophyloxis and treatment of diabetic complications
JPS63132889A (ja) * 1986-11-21 1988-06-04 Tanabe Seiyaku Co Ltd キナゾリノン誘導体
EP0306525A4 (en) * 1987-03-20 1991-04-24 Alcon Laboratories Inc Use of aldose reductase inhibitors to enhance insulin sensitivity in diabetes mellitus
US5202339A (en) * 1987-08-28 1993-04-13 Mochida Pharmaceutical Co., Ltd. Hydantoin derivatives
US5004751A (en) * 1987-08-28 1991-04-02 Mochida Pharmaceutical Co., Ltd. Hydantoin derivatives
FI902028A7 (fi) * 1988-08-24 1990-04-23 Mochida Pharm Co Ltd Hydantoiinijohdannaisia
US5068332A (en) * 1990-10-12 1991-11-26 American Home Products Corporation Alkylidene analogs of 1'-aminospiro[isoquinoline-4(1H),3'-pyrrolidine]-1,2',3,5'(2H)-tetrones useful as aldose reductase inhibitors
US8326636B2 (en) * 2008-01-16 2012-12-04 Canyon Ip Holdings Llc Using a physical phenomenon detector to control operation of a speech recognition engine
JP6105631B2 (ja) * 2012-02-09 2017-03-29 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング １，４−保護９−ヒドロキシ−５−オキソ−１，４−ジアザ−スピロ［５．５］ウンデカンの立体選択的合成方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1088945A (en) * 1976-10-18 1980-11-04 Pfizer Limited Hydantoin derivatives as therapeutic agents
US4117230A (en) 1976-10-18 1978-09-26 Pfizer Inc. Hydantoin derivatives as therapeutic agents
US4235911A (en) * 1979-06-13 1980-11-25 Pfizer Inc. Hydantoin derivatives
US4248882A (en) * 1980-02-12 1981-02-03 Pfizer Inc. Treating diabetes-associated complications with hydantoin amines
JPS5745185A (en) * 1980-07-21 1982-03-13 Eisai Co Ltd Hydantoin derivative and its preparation
DE3367103D1 (en) * 1982-11-10 1986-11-27 Pfizer Sorbinil by optical resolution with aminopinane derivatives
US4556670A (en) 1982-12-06 1985-12-03 Pfizer Inc. Spiro-3-hetero-azolones for treatment of diabetic complications
HU193191B (en) * 1982-12-06 1987-08-28 Pfizer Process for preparing spiro-hetero-azolones
DE3561198D1 (en) * 1984-03-23 1988-01-28 Pfizer Spiro-indenes and spiro-1,2-dihydro-naphthalenes for treatment of diabetic complications
US4762838A (en) 1985-08-30 1988-08-09 Pfizer Inc. Quinazolin-4(3H)-one derivatives as anticoccidial agents

Also Published As

Publication number Publication date
HUT49882A (en) 1989-11-28
NO862123L (no) 1986-12-01
PT82650B (pt) 1988-11-30
HU199845B (en) 1990-03-28
PH22213A (en) 1988-06-28
DE3665584D1 (de) 1989-10-19
ES8801830A1 (es) 1988-02-16
DD264215A5 (de) 1989-01-25
EP0203791B1 (en) 1989-09-13
US4575507A (en) 1986-03-11
PL266365A1 (en) 1988-03-03
PL147400B1 (en) 1989-05-31
FI862251A0 (fi) 1986-05-28
AU560429B2 (en) 1987-04-09
HU893127D0 (en) 1990-01-28
DD251972A5 (de) 1987-12-02
ATE46332T1 (de) 1989-09-15
PL147397B1 (en) 1989-05-31
PL147398B1 (en) 1989-05-31
PL146020B1 (en) 1988-12-31
DK248886D0 (da) 1986-05-28
ZA863934B (en) 1988-01-27
PL266364A1 (en) 1988-03-03
ES555375A0 (es) 1987-11-01
ES8800228A1 (es) 1987-11-01
PL266363A1 (en) 1988-03-03
PT82650A (en) 1986-06-01
DD273258A5 (de) 1989-11-08
DK248886A (da) 1986-11-30
GR861388B (en) 1986-09-17
HU196060B (en) 1988-09-28
KR860008984A (ko) 1986-12-19
JPS61277671A (ja) 1986-12-08
AU5801286A (en) 1987-01-08
DD264213A5 (de) 1989-01-25
PL266366A1 (en) 1988-03-03
EG17859A (en) 1991-11-30
EP0203791A1 (en) 1986-12-03
FI862251A7 (fi) 1986-11-30
NZ216334A (en) 1988-08-30
KR890001548B1 (en) 1989-05-08
DD264214A5 (de) 1989-01-25
HUT49879A (en) 1989-11-28
PL147399B1 (en) 1989-05-31
HUT44767A (en) 1988-04-28
IL78954A (en) 1989-09-28
IL78954A0 (en) 1986-09-30
FI862251L (fi) 1986-11-30

Similar Documents

Publication Publication Date Title
FI870219A0 (fi) Hypoglykemiska tiazolidindioner.
DK275488A (da) Indolonderivater
GR3004278T3 (es)
FI893632A0 (fi) Foereningar.
ES555375A0 (es) Un procedimiento para la preparacion de espiro (imidiazolina-4,1'-(2'h)-naftaleno) y espiro (croman-4,4'-imidazolidinas)
ZA89389B (en) Use of 1,4-disubstituted-piperidinyl compounds in the manufacture of a medicament for the treatment of insomnia
SE8500996D0 (sv) Method of treatment
ES2016305B3 (es) Compuestos de piperazina, procedimiento para prepararlos y composicion farmaceutica y su uso.
DK13484A (da) Forbindelser med antihypertensiv virkning
NO861868L (no) Fremgangsmaate for fremstilling av terapeutisk aktive 1,3-oksatian-derivater.
MX9205408A (es) Metodo para tratar hipertension.